publicaciones seleccionadas artículo académico Agonistic effect of peptides derived from a truncated HMGB1 acidic tail sequence in TLR5 from Salmo salar. FISH & SHELLFISH IMMUNOLOGY. 144. 2024 Design and functional characterization of Salmo salar TLR5 agonist peptides derived from high mobility group B1 acidic tail. FISH & SHELLFISH IMMUNOLOGY. 146. 2024 New insight into the biological activity of Salmo salar NK-lysin antimicrobial peptides. FRONTIERS IN IMMUNOLOGY. 15. 2024 ANTIMICROBIAL SINERGY EVALUATION OF LACTIC BACTERIA STRAINS AGAINST PATHOGENS. CIENCIA VETERINARIA. 25(1):1-22. 2023 Chitosan Microparticles Enhance the Intestinal Release and Immune Response of an Immune Stimulant Peptide in Oncorhynchus mykiss. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 24(19). 2023 Co-Formulation of Recombinant Porcine IL-18 Enhances the Onset of Immune Response in a New Lawsonia intracellularis Vaccine. VACCINES. 11(12). 2023 Effects of recombinant FSH (bscrFSH) and pituitary FSH (FSH-p) on embryo production in superovulated dairy heifers inseminated with unsorted and sex-sorted semen. ANIMAL REPRODUCTION SCIENCE. 252. 2023 First report of bovine viral diarrhea virus subgenotypes 1d and 1e in southern Chile. VIROLOGY JOURNAL. 20(1). 2023 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 24(6). 2023 Immunomodulatory role of vasoactive intestinal peptide and ghrelin in Oncorhynchus mykiss. HELIYON. 9(12). 2023 Isolation, characterization, and immunomodulatory activity evaluation of probiotic strains from colostrum and canine milk. FRONTIERS IN VETERINARY SCIENCE. 10. 2023 New Formulation of a Subunit Vaccine Candidate against Lawsonia intracellularis Increases Humoral and Cellular Immune Responses. VACCINES. 11(12). 2023 FISH & SHELLFISH IMMUNOLOGY. FISH & SHELLFISH IMMUNOLOGY. 125:120-127. 2022 FISH & SHELLFISH IMMUNOLOGY. FISH & SHELLFISH IMMUNOLOGY. 121:387-394. 2022 INFECTIOUS SALMON ANEMIA VIRUS INFECTIVITY IS DETERMINED BY MULTIPLE SEGMENTS WITH AN IMPORTANT CONTRIBUTION FROM SEGMENT 5. VIRUSES-BASEL. 14(3). 2022 Long-term release of bioactive interferon-alpha from plga-chitosan microparticles: in vitro and in vivo studies. BIOMATERIALS ADVANCES. 143. 2022 A TRIVALENT TNF-R2 AS A NEW TUMOR NECROSIS FACTOR ALPHA-BLOCKING MOLECULE. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS. 89(11):1557-1564. 2021 CHARACTERISATION OF A NEW MOLECULE BASED ON TWO E2 SEQUENCES FROM BOVINE VIRAL DIARRHOEA-MUCOSAL DISEASE VIRUS FUSED TO THE HUMAN IMMUNOGLOBULIN FC FRAGMENT. JOURNAL OF VETERINARY RESEARCH. 65(1):27-37. 2021 ESTABLISHMENT OF A PRODUCTION PROCESS FOR A NOVEL VACCINE CANDIDATE AGAINST LAWSONIA INTRACELLULARIS. ELECTRONIC JOURNAL OF BIOTECHNOLOGY. 50:45-52. 2021 EXPRESSION AND CHARACTERIZATION OF A NOVEL SINGLE-CHAIN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODY IN THE GOAT MILK. JOURNAL OF BIOTECHNOLOGY. 338:52-62. 2021 IN VIVO MODIFICATION OF THE GOAT MAMMARY GLAND GLYCOSYLATION PATHWAY. NEW BIOTECHNOLOGY. 61:11-21. 2021 RAMAN SPECTROSCOPY AND SILVER NANOPARTICLES FOR EFFICIENT DETECTION OF MEMBRANE PROTEINS IN LIVING CELLS. NANOTECHNOLOGY. 32(49). 2021 A HETEROLOGOUS VIRAL PROTEIN SCAFFOLD FOR CHIMERIC ANTIGEN DESIGN: AN EXAMPLE PCV2 VIRUS VACCINE CANDIDATE. VIRUSES-BASEL. 12(4). 2020 BIOMOLECULES. BIOMOLECULES. 10(3). 2020 FLUORESCENCE-ASSISTED SEQUENTIAL INSERTION OF TRANSGENES (FASIT): AN APPROACH FOR INCREASING SPECIFIC PRODUCTIVITY IN MAMMALIAN CELLS. SCIENTIFIC REPORTS. 10(1):1-6. 2020 LOX-1 IN CARDIOVASCULAR DISEASES, FUTURE THERAPEUTIC PERSPECTIVES. REVISTA BIONATURA. 5(2):1156-1161. 2020 NEW INSIGHTS ON THE INTERACTION MECHANISM OF RHTNFA WITH ITS ANTAGONISTS ADALIMUMAB AND ETANERCEPT. BIOCHEMICAL JOURNAL. 477(17):3299-3311. 2020 POLYMERIC NANOENCAPSULATION OF ALPHA INTERFERON INCREASES DRUG BIOAVAILABILITY AND INDUCES A SUSTAINED ANTIVIRAL RESPONSE IN VIVO. MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS. 116:1-6. 2020 PRO-FIBROTIC EFFECT OF OXIDIZED LDL IN CARDIAC MYOFIBROBLASTS. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 524(3):696-701. 2020 RAPID SEQUENCE MODIFICATION IN THE HIGHLY POLYMORPHIC REGION (HPR) OF THE HEMAGGLUTININ GENE OF THE INFECTIOUS SALMON ANAEMIA VIRUS (ISAV) SUGGESTS INTRA-SEGMENTAL TEMPLATE SWITCHING RECOMBINATION. JOURNAL OF FISH DISEASES. 43(12):1483-1496. 2020 AAV PURIFICATION BY ANION-EXCHANGE CHROMATOGRAPHY. REVISTA BIONATURA. 4(1):771-774. 2019 FISH & SHELLFISH IMMUNOLOGY. FISH & SHELLFISH IMMUNOLOGY. 88:587-594. 2019 MULTI-ANTIGENIC RECOMBINANT SUBUNIT VACCINE AGAINST LAWSONIA INTRACELLULARIS: THE ETIOLOGICAL AGENT OF PORCINE PROLIFERATIVE ENTEROPATHY. VACCINE. 37(10):1340-1349. 2019 NEUROPROTECTIVE EFFECTS OF EPOL AGAINST OXIDATIVE STRESS INDUCED BY SOLUBLE OLIGOMERS OF A BETA PEPTIDE. INTERNATIONAL JOURNAL FOR PARASITOLOGY-PARASITES AND WILDLIFE. 24:1-12. 2019 ACTIVATION OF MEMBRANE-BOUND AND SOLUBLE TOLL-LIKE RECEPTORS 5 IN SALMO SALAR DEPENDS ON THE MYD88 SIGNALLING PATHWAY. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. 1862(10):2215-2225. 2018 LOX-1 ACTIVATION BY OXLDL TRIGGERS AN EPITHELIAL MESENCHYMAL TRANSITION AND PROMOTES TUMORIGENIC POTENTIAL IN PROSTATE CANCER CELLS. CANCER LETTERS. 414:34-43. 2018 NEUROPROTECTIVE EFFECT OF A NEW VARIANT OF EPO NONHEMATOPOIETIC AGAINST OXIDATIVE STRESS. REDOX BIOLOGY. 14:285-294. 2018 QUANTITATIVE ELISA SANDWICH FOR A NEW VACCINE AGAINST AVIAN INFLUENZA VIRUS H5N1. JOURNAL OF IMMUNOLOGICAL METHODS. 459:70-75. 2018 EXPRESSION AND PURIFICATION OF THE SURFACE PROTEINS FROM ANDES VIRUS. PROTEIN EXPRESSION AND PURIFICATION. 139:63-70. 2017 TRANSIENT EXPRESSION OF FUNCTIONAL GLUCOCEREBROSIDASE FOR TREATMENT OF GAUCHER'S DISEASE IN THE GOAT MAMMARY GLAND. MOLECULAR BIOTECHNOLOGY. 58(1):47-55. 2016 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 467(4):1039-1045. 2015 BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. 1850(9):1685-1693. 2015 CIS-REGULATORY ELEMENTS INVOLVED IN SPECIES-SPECIFIC TRANSCRIPTIONAL REGULATION OF THE SVCT1 GENE IN RAT AND HUMAN HEPATOMA CELLS. FREE RADICAL BIOLOGY AND MEDICINE. 85:183-196. 2015 SECRETION AND ASSEMBLY OF CALICIVIRUS-LIKE PARTICLES IN HIGH-CELL-DENSITY YEAST FERMENTATIONS:STRATEGIES BASED ON A RECOMBINANT NON-SPECIFIC BPTI-KUNITZ-TYPE PROTEASE INHIBITOR. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY. 99:3875-3886. 2015 EFFECTIVENESS OF THE E2-CLASSICAL SWINE FEVER VIRUS RECOMBINANT VACCINE PRODUCED AND FORMULATED WITHIN THE WHEY OF GENETICALLY TRANSFORMED GOATS. CLINICAL AND VACCINE IMMUNOLOGY. 21(12):1628-1634. 2014 ENDOTHELIUM TRANS DIFFERENTIATED FROM WHARTON'S JELLY MESENCHYMAL CELLS PROMOTE TISSUE REGENERATION: POTENTIAL ROLE OF SOLUBLE PRO-ANGIOGENIC FACTORS. PLOS ONE. 9(11):1-10. 2014 LECTIN-LIKE OXIDIZED LDL RECEPTOR-1 IS AN ENHANCER OF TUMOR ANGIOGENESIS IN HUMAN PROSTATE CANCER CELLS. PLOS ONE. 9(8):1-11. 2014 CONFORMATIONAL AND THERMAL STABILITY IMPROVEMENTS FOR THE LARGE-SCALE PRODUCTION OF YEAST-DERIVED RABBIT HEMORRHAGIC DISEASE VIRUS-LIKE PARTICLES AS MULTIPURPOSE VACCINE. PLOS ONE. 8(2):1-16. 2013 FIRST REPORT OF BOVINE HERPESVIRUS 5 IN BULL SEMEN. ARCHIVES OF VIROLOGY. 157(9):1775-1778. 2012 AVIAN CD154 ENHANCES HUMORAL AND CELLULAR IMMUNE RESPONSES INDUCED BY AN ADENOVIRUS VECTOR-BASED VACCINE IN CHICKENSHE. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES. 0. 2011 DUAL PROMOTER LENTIVIRAL VECTOR GENERATES TRANSGENIC MICE EXPRESSING E2-CSFV GLYCOPROTEIN IN THEIR MILK, BUT IMPAIRS EARLY IDENTIFICATION OF THE TRANSGENIC EMBRYOS. THERIOGENOLOGY. 0. 2011 SINGLE DOSE ADENOVIRUS VECTORED VACCINE INDUCES A POTENT AND LONG-LASTING IMMUNE RESPONSE AGAINST RABBIT HEMORRHAGIC DISEASE VIRUS AFTER PARENTERAL OR MUCOSAL ADMINISTRATION. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY. 0. 2011 ALL ROADS LEAD TO MILK: TRANSGENIC AND NON-TRANSGENIC APPROACHES FOR EXPRESSION OF RECOMBINANT PROTEINS IN THE MAMMARY GLAND. ACTA SCIENTIAE VETERINARIAE. 38(2):615-627. 2010 EARLY ONSET AND LONG LASTING PROTECTION IN PIGS PROVIDED BY A CLASSICAL SWINE FEVER E2-VACCINE CANDIDATE PRODUCED IN THE MILK OF GOATS. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY. 133(1):25-32. 2010 HUMAN ALFAIFN CO-FORMULATED WITH MILK DERIVED E2-CSFV PROTEIN INDUCE EARLY FULL PROTECTION IN VACCINATED PIGS. VACCINE. 0. 2010